 NEW YORK, July 30, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Misonix, Inc. Misonix or the Company NASDAQ: MSON in connection with the proposed cash-and-stock acquisition of the Company by Bioventus Inc. Bioventus NASDAQ: BVS. Under the terms of the merger agreement, Misonix shareholders may elect to receive either i 1.6839 shares of Bioventus stock, representing implied per-share merger consideration of approximately 29.05 based upon Bioventuss July 29, 2021 closing price of 17.25, or ii 28.00 in cash, without interest, for each share of Misonix common stock they hold, subject to proration based on an aggregate maximum cash amount payable by Bioventus equal to 10.50 per share of Misonix stock outstanding shortly prior to the completion of the transaction. 